FDA Approves Denosumab Biosimilar for Skeletal-Related Events, GCTB, and Hypercalcemia of Malignancy
FDA Approves Denosumab Biosimilar for Skeletal-Related Events, GCTB, and Hypercalcemia of Malignancy OncLive
Regulatory Approvals
Can You Monitor Glucose Without A Needle Or A Prescription? FDA Clears A New Biosensor
Can You Monitor Glucose Without A Needle Or A Prescription? FDA Clears A New Biosensor Beyond Type 1
Idea to Industry: Built to Clear FDA: A Prototyping Framework That Works
Idea to Industry: Built to Clear FDA: A Prototyping Framework That Works Johns Hopkins University
Behind the FDA approval of belzutifan plus lenvatinib in advanced ccRCC, with Robert Motzer, MD
Behind the FDA approval of belzutifan plus lenvatinib in advanced ccRCC, with Robert Motzer, MD Urology Times
FDA Approves Mavacamten for Pediatric Patients With Obstructive HCM
FDA Approves Mavacamten for Pediatric Patients With Obstructive HCM HCPLive